Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Aug 12, 2020 2:36am
224 Views
Post# 31396305

QSC news say opening testing centres in real estate offices

QSC news say opening testing centres in real estate offices https://finance.yahoo.com/news/questcap-announces-letter-intent-acquire-120000125.html

The first phase of testing is the establishment of 11 pop-up labs, also known as ‘draw centres’, that can together administer 5,500 tests per day, with a capacity to analyze 154,000 tests a month.  The first site opened for business in Las Vegas on August 8, 2020. Additional locations are expected to open throughout Las Vegas, as well as Arizona, Texas, and Indiana within the next couple of weeks.  The draw centres will be located in malls, retail centers, fitness facilities, pharmacies, stadiums, on-site in small businesses, real estate offices, law firms and schools. The second phase, expected to launch in fall 2020, will include mobile pop-up labs to provide access to those without transportation or unable to travel.

Can that be related to this news

https://www.newswire.ca/news-releases/resaas-secures-8-minute-covid-19-rapid-tests-for-real-estate-agents-826333330.html

RESAAS has access to 1,000,000 units immediately available for sale.

Here is part of that news from REAAAS

The tests are manufactured by PCL, a publicly traded medical company headquartered in South Korea. Health authorities have approved the 8-Minute Rapid Test in Argentina, Australia, Brazil, China, Germany, Japan, Spain, and 20 other countries.

As PCL did not get FDA approval, so they might be switching to new tests.

<< Previous
Bullboard Posts
Next >>